Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
NITRAZEPAM
Ranbaxy Ireland Limited
NITRAZEPAM
5 mg Milligram
Tablets
Product subject to prescription which may not be renewed (A)
Withdrawn
2010-09-10
IRISH MEDICINES BOARD ACT 1995 MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998 (S.I. NO.142 OF 1998) PA0408/026/001 Case No: 2032801 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to RANBAXY IRELAND LIMITED SPAFIELD, CORK ROAD, CASHEL, CO. TIPPERARY, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product NITRAZEPAM TABLETS BP 5 MG The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 15/02/2007. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 16/02/2007_ _CRN 2032801_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nitrazepam Tablets BP 5 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Nitrazepam 5mg. Excipient: Also contains 443mg lactose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet A white, circular tablet embossed 'RN5' on one side and a breakline on the other side. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Insomnia Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Insomnia Treatment should be as short as possible. Generally, the duration Lue koko asiakirja